HCV Therapy | Room 716

Saturday, June 16, 2018
10:30 AM to 12:15 PM

Chairs: Mark Sulkowski & Antonio Craxi

Invited Presentations:

10:30am
Debate: Acute HCV – to treat or wait?
Ira Jacobson, NYU Langone Health, New York & Susanna Naggie, Duke University, Durham

10:55am
When and how to treat decompensated patients with HCV
Xavier Forns, Liver Unit Hospital Clinic Barcelona, Barcelona

11:20am
Treating HCV outside of the liver: management of extrahepatic manifestations
Francesco Negro, University Hospitals Of Geneva, Geneva

Oral Abstracts:

11:45am
Directly Acting Antiviral HCV Therapy is Safe and Effective in Patients with Advanced Cirrhosis: Real World Experience from the HCV-TARGET Cohort
Raj Reddy, University Of Florida, Gainesville 

12:00pm
Analysis of AST to Platelet Ratio Index (APRI) for Determining Eligibility for 8 Weeks of Glecaprevir/ Pibrentasvir
Tarik Asselah, Abbvie, Inc., North Chicago